Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ISX:SILO'
s EV-to-FCF Range Over the Past 10 Years
Min: -524.52 Med: 14.09 Max: 104.6
Current: 38.37
During the past 13 years, the highest EV-to-FCF of PT Siloam International Hospitals Tbk was 104.60. The lowest was -524.52. And the median was 14.09.
ISX:SILO's EV-to-FCF is ranked worse than 79.21% of 404
companies
in the Healthcare Providers & Services industry
Industry Median: 18.215
vs ISX:SILO: 38.37
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Siloam International Hospitals Tbk (ISX:SILO) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Siloam International Hospitals Tbk's PE Ratio (TTM) for today is calculated as:
PT Siloam International Hospitals Tbk's share price for today is Rp2180.00.
PT Siloam International Hospitals Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp88.280.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Siloam International Hospitals Tbk EV-to-FCF Related Terms
PT Siloam International Hospitals Tbk EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk EV-to-FCF Chart
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's EV-to-FCF falls into.
PT Siloam International Hospitals Tbk's current Enterprise Value is Rp29,476,067 Mil.
PT Siloam International Hospitals Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp768,219 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk (ISX:SILO) has a EV-to-FCF of 38.37 as of Jul. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Siloam International Hospitals Tbk and its competitors. This is 172% above median its historical median of 14.09. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #320 out of 404 companies in the Healthcare Providers & Services industry, placing it in the top 79.2%.
Is PT Siloam International Hospitals Tbk's EV-to-FCF too high?
PT Siloam International Hospitals Tbk's current EV-to-FCF of 38.37 is 172% above median its 10-year median of 14.09. The Healthcare Providers & Services industry median EV-to-FCF is 18.22. PT Siloam International Hospitals Tbk's value of 38.37 is 110.7% above this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #320 out of 404 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #320 out of 404 companies for EV-to-FCF. This places PT Siloam International Hospitals Tbk in the lower half of its industry. The industry median EV-to-FCF is 18.22. PT Siloam International Hospitals Tbk's value of 38.37 is 110.7% above this benchmark. While the company's 10-year median is 14.09 vs. the industry median of 18.22, PT Siloam International Hospitals Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.22, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current EV-to-FCF of 38.37 is 110.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current EV-to-FCF is 38.37, which is 172% above median its own 10-year median of 14.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (ISX:SILO) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp2,784.82, compared to a current price of Rp2,180.00 — trading 21.7% below its estimated fair value. The current EV-to-FCF is 38.37, which is 172% above median its 10-year median of 14.09 and 110.7% above the Healthcare Providers & Services industry median of 18.22. PT Siloam International Hospitals Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (ISX:SILO), the current EV-to-FCF is 38.37 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (ISX:SILO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of Rp2,180.00 is trading 21.7% below its estimated GF Value™ of Rp2,784.82.
GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SILO:
EV-to-FCF: 38.37 (172% above median its 10-year median of 14.09)
GF Value™: Rp2,784.82 vs. price of Rp2,180.00 (21.7% below fair value)
Industry Position: 110.7% above the Healthcare Providers & Services median (#320 of 404)
No single metric tells the full story. See the ISX:SILO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
91GF Score
Get the complete analysis for ISX:SILO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SILO has been successfully added to your 
